Alpha 2.0
Login Register
» Authors » Steven J Warrington

Steven J Warrington

Explore the profile of Steven J Warrington including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 95
Followers 0
Related Specialties
Pharmacology
Biomedical Engineering
Urology
Top 10 Co-Authors
Joan R Butterton
Matthew L Rizk
Michael S Schwartz
Eric Mangin
Yang Liu
Kathy J Baisley
Francheska Colon-Gonzalez
Elizabeth G Rhee
Marcela Nefliu
Pratik Bhagunde
Published In
Antimicrob Agents Chemother
BJU Int
Vaccine
Br J Clin Pharmacol
West J Emerg Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Rapid Cycle Deliberate Practice in Virtual Reality: Teaching Transvenous Pacemaker Insertion to Emergency Medicine Residents
Peng C, Ng K, Roszczynialski K, Warrington S, Schertzer K
Cureus . 2021 Nov; 13(10):e18503. PMID: 34754663
Introduction Transvenous pacemaker insertion is a critical life-saving procedure that is infrequently performed. Traditional mannequin-based training paradigms are resource intensive and sometimes inadequate due to time constraints. Rapid Cycle Deliberate...
2.
Erratum for Rhee et al., "Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants"
Rhee E, Rizk M, Calder N, Nefliu M, Warrington S, Schwartz M, et al.
Antimicrob Agents Chemother . 2018 Nov; 62(12). PMID: 30478180
No abstract available.
3.
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants
Rhee E, Rizk M, Calder N, Nefliu M, Warrington S, Schwartz M, et al.
Antimicrob Agents Chemother . 2018 Jun; 62(9). PMID: 29914955
Relebactam is a novel class A and C β-lactamase inhibitor that is being developed in combination with imipenem-cilastatin for the treatment of serious infections with Gram-negative bacteria. Here we report...
4.
A novel peptide-based pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety
Francis J, Bunce C, Horlock C, Watson J, Warrington S, Georges B, et al.
Vaccine . 2014 Jun; 33(2):396-402. PMID: 24928790
Background: FP-01.1 is a novel synthetic influenza A vaccine consisting of six fluorocarbon-modified 35-mer peptides that encapsulate multiple CD4+ and CD8+ T-cell epitopes and is designed to induce an immune...
5.
Are Simulation Stethoscopes a Useful Adjunct for Emergency Residents' Training on High-fidelity Mannequins?
Warrington S, Beeson M, Fire F
West J Emerg Med . 2013 May; 14(3):275-7. PMID: 23687548
Introduction: Emergency medicine residents use simulation training for many reasons, such as gaining experience with critically ill patients and becoming familiar with disease processes. Residents frequently criticize simulation training using...
6.
Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study
Boyce M, Baisley K, Warrington S
Br J Clin Pharmacol . 2011 Sep; 73(3):411-21. PMID: 21883386
Aims: To assess the steady-state pharmacokinetic and QT(c) effects of domperidone and ketoconazole, given alone and together. Methods: A randomized, placebo-controlled, double-blind, crossover study was carried out. Healthy subjects (14...
7.
Are published normal ranges of serum testosterone too high? Results of a cross-sectional survey of serum testosterone and luteinizing hormone in healthy men
Boyce M, Baisley K, Clark E, Warrington S
BJU Int . 2004 Oct; 94(6):881-5. PMID: 15476527
Objective: To derive normal ranges of serum testosterone and luteinizing hormone (LH) concentrations in healthy men, and thus evaluate whether testosterone replacement therapy is prescribed inappropriately. Subjects And Method: The...